AzTrials
AzTrials

ColonoscopyNCT04912037

A Study on the Effectiveness of AI-assisted Colonoscopy in Improving the Effect of Colonoscopy Training for Trainees

A study testing artificial intelligence assistance system in people with Colonoscopy and Artificial Intelligence, run by Renmin Hospital of Wuhan University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study,the AI-assisted system(EndoAngel)has the functions of reminding the ileocecal junction, withdrawal time, withdrawal speed, sliding lens, polyps in the field of vision, etc. These functions can improve the colonoscopy performance of novice physicians and assist the colonoscopy training。 Read more about this study

Who is it for?
Ages 50 years and older
What is being tested?
artificial intelligence assistance system
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
385 participants
Where
1 siteChina
Study dates
1 Jun 2021to 1 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female ≥50 years old;
  • Able to read, understand and sign informed consent
  • The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures
  • Patients requiring colonoscopy

Who cannot join

  • Have drug or alcohol abuse or mental disorder in the last 5 years
  • Pregnant or lactating women
  • Patients with known multiple polyp syndrome;
  • patients with known inflammatory bowel disease;
  • known intestinal stenosis or space-occupying tumor;
  • known colon obstruction or perforation;
Show all 10Show fewer
  • patients with a history of colorectal surgery;
  • Patients with previous history of allergy to pre-used spasmolysis;
  • Unable to perform biopsy and polyp removal due to coagulation disorders or oral anticoagulants;
  • High risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.

Trial locations and contacts

1 site in 1 country.

Yu W Honggang, Doctor contact

+862788041911

whdxrmyy@126.com

Yu Honggang, Doctor contact

+862788041911

whdxrmyy@126.com

China1 site, 1 recruiting
  • Renmin hospital of Wuhan University

    Wuhan, Hubei, 430000

    Honggang Yu, Doctor, +862788041911, whdxrmyy@126.com

    Recruiting

Other trials in China

About this study

Official title: A Study on the Effectiveness of Artificial Intelligence-assisted Colonoscopy in Improving the Effect of Colonoscopy Training for Trainees

In this study,the AI-assisted system(EndoAngel)has the functions of reminding the ileocecal junction, withdrawal time, withdrawal speed, sliding lens, polyps in the field of vision, etc. These functions can improve the colonoscopy performance of novice physicians and assist the colonoscopy training。

Read the detailed description

Colonoscopy is a key technique for detecting and diagnosing lesions of the lower digestive tract.High-quality endoscopy leads to better disease outcomes.However, the demand for endoscopy is high in China, and endoscopy is in short supply.A colonoscopy is a complex technical procedure that requires training and experience for maximal accuracy and safety.Therefore, it is of great significance to improve the colonoscopy ability of novice physicians and shorten the colonoscopy training time for solving the problems such as the lack and uneven distribution of digestive endoscopists and the substandard quality of endoscopy in China.

In recent years, deep learning algorithms have been continuously developed and increasingly mature.They have been gradually applied to the medical field. Computer vision is a science that studies how to make machines "see". Through deep learning, camera and computer can replace human eyes to carry out machine vision such as target recognition, tracking and measurement.Interdisciplinary cooperation in the field of medical imaging and computer vision is also one of the research hotspots in recent years. At present, it is mainly applied to the automatic identification and detection of lesions and quality control, and has achieved good results.

Our preliminary experiments have shown that deep learning has a high accuracy in endoscopic quality monitoring, which can effectively regulate doctors' operations, reduce blind spots and improve the quality of endoscopic examination.At the same time, it can also monitor the doctor's withdrawal time in real time and improve the detection rate of adenoma.In the previous work of our research group, we have successfully developed deep learning-based colonoscopy withdraw speed monitoring and intestinal cleanliness assessment, and verified the effectiveness of the AI-assisted system(EndoAngel) in improving the quality of gastroscopy and colonoscopy in clinical trials.

Based on the above rich foundation of preliminary work, as well as the huge demand in the field of colonoscopy training,By comparing the colonoscopy operation training for novices with and without EndoAngel assistance, we plan to compare the colonoscopy learning effect of novices with and without assistance, including skill results and cognitive level, to explore whether AI can promote the improvement of the colonoscopy operation training for novices.

Being tested
artificial intelligence assistance system
Medical subject headings
Gastrointestinal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • artificial intelligence assistance systemDevice

    the artificial intelligence assistance system can indicate abnormal lesions and real-time withdrawal speed, and feedback the overspeed percentage.

Study groups in NCT04912037
Study groupRoleWhat they receive
with AI-assisted systemExperimentalThe novice doctors are trained in colonoscopy with an artificial intelligence assisted system that can indicate abnormal lesions and the speed of withdrawal in real time, as well as feedback on the percentage of overspeed.
Receives: Device: artificial intelligence assistance system
without AI-assisted systemNo interventionThe novice doctors receive routine colonoscopy training without artificial intelligence assistance system and no special tips

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CUSUM learning curve for colonoscopy (ACE scoring scale)

    Measured: From the beginning to the end of colonoscopy training

  2. Average test score difference before and after training

    Measured: From the beginning to the end of colonoscopy training

Secondary outcomes (14)
  1. Detection rate of advanced adenoma

    The numerator is the number of patients diagnosed with advanced adenomas, and the denominator is the total number of patients undergoing colonoscopy,Advanced adenoma was defined as > 10mm adenoma, villous adenoma, tubular villous adenoma, high-grade intraepithelial neoplasia, and carcinoma.

    Measured: A month

  2. Polyp Detection Rate, PDR

    The numerator is the number of patients with polyps detected by colonoscopy, and the denominator is the total number of patients who underwent colonoscopy

    Measured: A month

  3. Average number of adenomas detected per patient

    The numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.

    Measured: A month

  4. The detection rate of large, small and micro polyps

    The numerator is the number of patients with large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) polyps detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.

    Measured: A month

  5. The average number of large, small and micro polyps detected

    The numerator is the total number of large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) polyps detected by colonoscopy, and denominator is the total number of patients undergoing colonoscopy.

    Measured: A month

  6. The detection rate of large, small and micro adenomas

    The numerator is the number of patients with large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) adenomas detected by colonoscopy, and the denominator is the total number of patients receiving colonoscopy.

    Measured: A month

  7. The average number of large, small and micro adenomas detected

    The numerator is the total number of large (≥10 mm), small (6-9 mm) and micro-small (≤5 mm) adenomas detected by colonoscopy, and denominator is the total number of patients undergoing colonoscopy.

    Measured: A month

  8. The detection rate of adenoma in different sites

    The numerator is the number of patients with adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon, ileocecal region and other sites during colonoscopy, and the denominator is the total number of patients receiving colonoscopy.

    Measured: A month

  9. The average number of adenomas detected in different sites

    The numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon, ileocecal region and other sites during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.

    Measured: A month

  10. Number of missed return of the sliding endoscopy/number of successful return of the sliding endoscopy

    The numerator is the total number of sliding endoscopy during colonoscopy, and the denominator is the number of sliding endoscopy and successful return endoscopy during colonoscopy

    Measured: A month

  11. Real-time gut cleanliness score

    During colonoscopy, a real-time intestinal cleanliness score was given by EndoAngel based on the Boston-scale Boreal Preparation Score (BBPS).

    Measured: During procedure

  12. withdraw overspeed percentage

    The ratio of the overspeed duration to the total duration in the process of withdrawal.

    Measured: During procedure

  13. The withdraw time

    The time between colonoscopy arrival at ileocecal valve and colonoscopy exit from anus.

    Measured: During procedure

  14. Ratio of ileocecal reach

    For a period of time, the number of colonoscopies that failed to reach the ileocecal part accounted for the proportion of the total number of colonoscopies.

    Measured: A month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2021
  2. Study start1 Jun 2021 (estimated)
  3. Primary completion1 Jan 2022 (estimated)
  4. Study completion1 Feb 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
385 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04912037
Sponsor's protocol ID
EA-21-005
Status last verified
May 2021
First submitted
28 May 2021
Last updated
3 Jun 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing artificial intelligence assistance system in people with Colonoscopy and Artificial Intelligence, run by Renmin Hospital of Wuhan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yu W Honggang, Doctor (+862788041911, whdxrmyy@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CUSUM learning curve for colonoscopy (ACE scoring scale) (time frame: From the beginning to the end of colonoscopy training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in